Application
BTN3A1 Antibody (C-term) western blot analysis in MDA-MB231 cell line lysates (35ug/lane).This demonstrates the BTN3A1 antibody detected the BTN3A1 protein (arrow).| Product Name | BTN3A1 Antibody (C-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | BTN3A1; BTF5; Butyrophilin subfamily 3 member A1; CD_antigen=CD277; Flags: Precursor |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:100~500 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | BTF5 |
|---|---|
| Alternative Names | BTN3A1 BTF5 Butyrophilin subfamily 3 member A1 CD_antigen=CD277 Flags: Precursor |
| Molecular Weight(MW) | 57677 Da |
| Function | Plays a role in T-cell activation and in the adaptive immune response. Regulates the proliferation of activated T-cells Regulates the release of cytokines and IFNG by activated T-cells Mediates the response of T-cells toward infected and transformed cells that are characterized by high levels of phosphorylated metabolites, such as isopentenyl pyrophosphate |
| Tissue Specificity | Detected on T-cells, natural killer cells, dendritic cells and macrophages (at protein level). Ubiquitous Highly expressed in heart, pancreas and lung, Moderately expressed in placenta, liver and muscle |
| Cellular Localization | Cell membrane; Single-pass type I membrane protein |
| Entrez Gene | 11119 |
|---|---|
| Nucleotide Accession | NP_001138481.1 NP_919423.1 NP_001138480.1 NP_008979.3 |
Application
BTN3A1 Antibody (C-term) western blot analysis in MDA-MB231 cell line lysates (35ug/lane).This demonstrates the BTN3A1 antibody detected the BTN3A1 protein (arrow).| Application Notes | WB:1:100~500 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
